인테그라 라이프사이언스 홀딩스 코퍼레이션
US ˙ NasdaqGS ˙ US4579852082

SecurityIART / Integra LifeSciences Holdings Corporation
InstitutionCipher Capital LP
Latest Disclosed Ownership9,129 shares
Latest Disclosed Value $ 323,623
Cipher Capital LP reports 34.00% decrease in ownership of IART / Integra LifeSciences Holdings Corporation

On May 15, 2024 - Cipher Capital LP filed a 13F-HR form disclosing ownership of 9,129 shares of Integra LifeSciences Holdings Corporation (US:IART) valued at $323,623 USD as of March 31, 2024. The entity filed a previous 13F-HR on February 14, 2024 disclosing 13,831 shares of Integra LifeSciences Holdings Corporation. This represents a change in shares of -34.00% during the quarter. The current value of the position is $155,102 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-05-15 2024-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 9,129 -4,702 -34.00 324 -46.35 0.1498
2024-02-14 2023-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 13,831 3,697 36.48 602 55.56 0.1951
2023-11-14 2023-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 10,134 -37,869 -78.89 387 -80.40 0.2744
2023-08-14 2023-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 48,003 32,027 200.47 1,974 115.27 0.3374
2023-05-15 2023-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 15,976 -25,951 -61.90 917 -60.98 0.1694
2023-02-13 2022-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 41,927 30,205 257.68 2,351 372.84 0.4436
2022-11-14 2022-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 11,722 11,722 497 0.0806
2020-11-13 2020-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -5,852 -100.00 0 -100.00
2020-08-14 2020-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,852 5,852 275 0.0435
2020-02-13 2019-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -22,019 -100.00 0 -100.00
2019-11-13 2019-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 22,019 22,019 1,322 0.1044
2017-08-09 2017-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 0 -28,617 -100.00 0 -100.00
2017-05-10 2017-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 28,617 28,617 1,206 0.0904
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.